HTC
BDTX icon

Hershey Trust Company’s Black Diamond Therapeutics BDTX Stock Holding History

Hershey Trust Company’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,836
Closed -$156K – 33
2021
Q2 		$156K Hold
12,836
– – ﹤0.01% 27
2021
Q1 		$311K Sell
12,836
-13,148
-51% -$355K ﹤0.01% 21
2020
Q4 		$833K Buy
25,984
+17,726
+215% +$582K 0.01% 14
2020
Q3 		$250K Buy
+8,258
New +$251K ﹤0.01% 15

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Hershey Trust Company's BDTX Position: Q3 2021 in Review

Hershey Trust Company sold out of Black Diamond Therapeutics (BDTX) in Q3 2021, closing a stake of 12,836 shares — an estimated $156K sold.

Hershey Trust Company first reported a position in BDTX in Q3 2020 and held it in 4 quarters. The position peaked at $833K in Q4 2020. 101 funds tracked by Wall St. Rank hold BDTX as of Q3 2021.

  • Hershey Trust Company reported no remaining Black Diamond Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Hershey Trust Company sold 12,836 Black Diamond Therapeutics shares in Q3 2021, an estimated $156K.
  • Hershey Trust Company first reported a position in Black Diamond Therapeutics in Q3 2020 and held it in 4 quarters.
  • Hershey Trust Company's Black Diamond Therapeutics position peaked at $833K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2021.

Based on Hershey Trust Company's 13F filing for Q3 2021, filed 12 Nov 2021.